Josep Dalmau

Active 1990–2025

271
Papers
71,922
Citations
134
h-index
263
i10-index

Citations

Citations per year for Josep Dalmau1986: 4 citations1990: 1 citations1991: 10 citations1992: 13 citations1993: 16 citations1994: 17 citations1995: 54 citations1996: 41 citations1997: 63 citations1998: 49 citations1999: 81 citations2000: 79 citations2001: 103 citations2002: 62 citations2003: 95 citations2004: 130 citations2005: 81 citations2006: 95 citations2007: 93 citations2008: 119 citations2009: 125 citations2010: 287 citations2011: 326 citations2012: 468 citations2013: 437 citations2014: 563 citations2015: 609 citations2016: 619 citations2017: 831 citations2018: 604 citations2019: 2,281 citations2020: 2,381 citations2021: 2,170 citations2022: 1,802 citations2023: 1,135 citations2024: 2,129 citations2025: 863 citations2026: 1 citations1987–1989: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,880 citing papers, 23.7% of this breakdownGermany: 714 citing papers, 9% of this breakdownUnited Kingdom: 628 citing papers, 7.9% of this breakdownChina: 604 citing papers, 7.6% of this breakdownFrance: 464 citing papers, 5.8% of this breakdownSpain: 435 citing papers, 5.5% of this breakdownItaly: 410 citing papers, 5.2% of this breakdownCanada: 244 citing papers, 3.1% of this breakdownNetherlands: 239 citing papers, 3% of this breakdownJapan: 237 citing papers, 3% of this breakdownAustralia: 220 citing papers, 2.8% of this breakdownAustria: 203 citing papers, 2.6% of this breakdown
0%23.7%Other 20.8%

Fields

  • Medicine77.6%
  • Neuroscience11.4%
  • Biochemistry, Genetics and Molecular Biology7.1%
  • Immunology and Microbiology1.9%
  • Psychology0.9%
  • Computer Science0.2%
  • Other0.9%

Topics

  • Autoimmune Neurological Disorders and Treatments17.2%
  • Peripheral Neuropathies and Disorders8.9%
  • Multiple Sclerosis Research Studies4.9%
  • Epilepsy research and treatment2.7%
  • Neuroscience and Neuropharmacology Research2.7%
  • Genetics and Neurodevelopmental Disorders2.2%
  • Other61.4%

Coauthors

All papers

Open in search
  1. A clinical approach to diagnosis of autoimmune encephalitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Neurology 2016 cited by 4,396

  2. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet Neurology 2013 cited by 3,094

  3. Antibody-Mediated Encephalitis

    Authors: , - New England Journal of Medicine 2018 cited by 1,315

  4. Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes

    Authors: , , , , , , , , , , , , , , , , , , - Neurology Neuroimmunology & Neuroinflammation 2021 cited by 708

  5. Paraneoplastic anti– N ‐methyl‐ D ‐aspartate receptor encephalitis associated with ovarian teratoma

    Authors: , , , , , , , , , , , , , , - Annals of Neurology 2007 cited by 2,466

  6. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies

    Authors: , , , , , , , , , - The Lancet Neurology 2008 cited by 3,459

  7. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models

    Authors: , , , , , , , , , , - The Lancet Neurology 2019 cited by 858

  8. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Izascun Arratibel, Gemma Aznar‐Laín, Paula Bellas-Lamas, Teresa de Jesús Bermejo, Sabas Boyero-Durán, Ana Camacho, Andrea del Campo, Dulce Campos, Verónica Cantarín Extremera, Cristóbal Carnero Pardo, David Conejo-Moreno, Marta Dapena, David Dacruz-Álvarez, Verónica Delgadillo-Chilavert, Àngela Deyà‐Martínez, Jordi Estela-Herrero, A. de Felipe, Elisa Fernández-Cooke, Joaquín Alejandro Fernández‐Ramos, Clàudia Fortuny, Juan Carlos García‐Moncó, Teresa Gili, Verónica González-Álvarez, Robert Güerri, Sara Guillén, Antonio Hedrera-Fernández, María López, Eduardo López‐Laso, María Lorenzo-Ruiz, Marcos Madruga, Ignacio Málaga, Itxaso Martí, Xavier Martínez-Lacasa, Lucía Martín-Viota, Leticia Martín Gil, María-Jesús Martínez-González, Antía Moreira, María Concepción Miranda-Herrero, L. Monge Galindo, Beatriz Muñoz Cabello, Juan Navarro‐Morón, Olaf Neth, Antoni Noguera‐Julián, Noemí Núñez‐Enamorado, Virginia Pomar, Juan C Portillo-Cuenca, M.S. Perez Poyato, Luís Prieto, Luís Querol, Eloy Rodríguez‐Rodríguez, Silvana Sarria‐Estrada, Concepción Sierra, Pere Soler‐Palacín, Víctor Soto-Insuga, Laura Toledo-Bravo, Miguel Tomás, Carmen Torres-Torres, Eulàlia Turón, Ana Zabalza - The Lancet Neurology 2018 cited by 648

  9. Cellular and Synaptic Mechanisms of Anti-NMDA Receptor Encephalitis

    Authors: , , , , , , , , , - Journal of Neuroscience 2010 cited by 1,127

  10. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis

    Authors: , , , , - The Lancet Neurology 2010 cited by 2,414

  11. Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System

    Authors: , , - Physiological Reviews 2017 cited by 635

  12. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study

    Authors: , , , , , , , , , , , - The Lancet Neurology 2013 cited by 1,286

  13. Clinical manifestations of the anti-IgLON5 disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Neurology 2017 cited by 414

  14. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study

    Authors: , , , , , , , , , , , , , , - The Lancet Neurology 2014 cited by 551

  15. Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gema Arriola-Pereda, Gemma Aznar‐Laín, Maite Benavides-Medina, Teresa de Jesús Bermejo, Raquel Blanco-Lago, Eva Caballero, Rocío Calvo, Ana Camacho Salas, David Conejo-Moreno, Verónica Delgadillo-Chilavert, Amagoia Elosegi-Castellanos, Vanesa Esteban Canto, Joaquín Alejandro Fernández‐Ramos, Montserrat García-Puig, Ainhoa García-Ribes, Hilario Gómez-Martín, Desire Gonzalez-Barrios, Luis González‐Gutiérrez‐Solana, Sara Jimena-Garcia, María Jiménez‐Legido, Natalia Juliá‐Palacios, Eduardo López‐Laso, Itxaso Martí, Marta Martínez González, Lucía Martín-Viota, Simone Mattozi, Elena Maqueda-Castellote, Maria del Mar Mendibe, Maria D Mora-Ramírez, Beatriz Muñoz Cabello, Juan Navarro‐Morón, Tania Nunes-Cabrera, Gabriela Orellana, Berta Pujol-Soler, Luís Querol, Alfredo Ramírez, María Isabel Rodríguez-Lucenilla, Cesar Ruiz, Víctor Soto-Insuga, Laura Toledo Bravo de Laguna, Eulalia Turón‐Viñas, María Vázquez López, Cristina Villar‐Vera - The Lancet Neurology 2020 cited by 326

  16. Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody Encephalitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ronny Wickström, Anusha K. Yeshokumar - JAMA Neurology 2021 cited by 212

  17. Diagnostic criteria for autoimmune encephalitis: utility and pitfalls for antibody-negative disease

    Authors: , - The Lancet Neurology 2023 cited by 166

  18. Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice

    Authors: , , , , , , , , , , , , , - Brain 2014 cited by 493

  19. The clinical spectrum of Caspr2 antibody–associated disease

    Authors: , , , , , , , , , , , , - Neurology 2016 cited by 433

  20. A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis

    Authors: , , , , , - Neurology 2018 cited by 295

  21. Interplay between persistent activity and activity-silent dynamics in the prefrontal cortex underlies serial biases in working memory

    Authors: , , , , , , , , , - Nature Neuroscience 2020 cited by 295

  22. LGI1 antibodies alter Kv1.1 and AMPA receptors changing synaptic excitability, plasticity and memory

    Authors: , , , , , , , , , , , , - Brain 2018 cited by 225

  23. Neuropathological criteria of anti-IgLON5-related tauopathy

    Authors: , , , , , , , , , , , , , , , , - Acta Neuropathologica 2016 cited by 239

  24. Clinical characterisation of patients in the post-acute stage of anti-NMDA receptor encephalitis: a prospective cohort study and comparison with patients with schizophrenia spectrum disorders

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marta Simó, E. Rodrı́guez, Juan José Ruiz Ezquerro, Luís Bataller, Gemma Safont, José Vicente-Hervàs, Luís Brieva, Ignacio Casado, Juan Carlos Portilla, Sonia Escalante, Juan F. Arenillas, Elena Erro, Ivonne Jericó-Pascual, Alejandro Fuerte‐Hortigón, Alba Morató, Albert Saiz, Yolanda Blanco, María Sepúlveda, Raquel Ruiz‐García, Laura Naranjo, Maria Rodés, Esther Aguilar, Mercedes Alba, Eva Caballero - The Lancet Neurology 2022 cited by 86